GLUCOSE-OXIDASE AS A TOOL TO STUDY IN-VIVO THE INTERACTION OF GLYCOSYLATED POLYMERS WITH THE MANNOSE RECEPTOR OF MACROPHAGES

被引:14
作者
DOMURADO, M [1 ]
DOMURADO, D [1 ]
VANSTEENKISTE, S [1 ]
DEMARRE, A [1 ]
SCHACHT, E [1 ]
机构
[1] STATE UNIV GHENT, DEPT ORGAN CHEM, BIOMAT & POLYMER RES GRP, B-9000 GHENT, BELGIUM
关键词
DEXTRAN; POLY-ASPARTAMIDE; GLUCOSE OXIDASE; GLYCOSYLATION; TARGETING; MANNOSE-RECEPTOR; RECEPTOR INHIBITION;
D O I
10.1016/0168-3659(94)00074-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In the present paper, we report the competition for the mannose-specific lectin of mononuclear phagocytes between two potential drug carriers, namely dextran and poly-alpha,beta-[N(2-hydroxyethyl)-D,L-aspartamide] (p-HEA) both modified by either alpha-D-mannose or beta-L-fucose residues, and glucose oxidase (G.O.) following intravenous coinjection into mice. Native dextran or p-HEA did not influence the plasma half-life time of G.O. On the other hand, coinjection of an excess of either alpha-D-mannosylated or beta L-fucosylated dextran of comparable sugar content did increase the circulation half-life time significantly. The extent by which the T1/2 of G.O. was prolonged, depended on sugar loading and the amount of competing polymer. Comparison between beta-L-fucosylated and alpha-D-mannosylated dextran revealed a slightly more efficient receptor inhibition by mannose. The effect of the macromolecular carrier nature was clearly demonstrated by comparison between dextran and p-HEA conjugates. All glycosylated p-HEA derivatives retarded the blood clearance of G.O. less than the dextran analogues. Further competition experiments revealed a rather peculiar in vivo behaviour of modified dextrans, probably due to adsorption phenomena on blood cell membranes.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 23 条
[21]  
VANSTEENKISTE S, 1993, ACS SYM SER, V520, P362
[22]  
VERT M, 1986, Critical Reviews in Therapeutic Drug Carrier Systems, V2, P291
[23]   GLUCOSE-OXIDASE - AN IDEAL ENZYME [J].
WILSON, R ;
TURNER, APF .
BIOSENSORS & BIOELECTRONICS, 1992, 7 (03) :165-185